Literature DB >> 21115159

Carney complex and other conditions associated with micronodular adrenal hyperplasias.

Madson Q Almeida1, Constantine A Stratakis.   

Abstract

Carney complex (CNC) is a multiple neoplasia syndrome that is inherited in an autosomal dominant manner and is characterized by skin tumors and pigmented lesions, myxomas, schwannomas, and various endocrine tumors. Inactivating mutations of the PRKAR1A gene coding for the regulatory type I-α (RIα) subunit of protein kinase A (PKA) are responsible for the disease in most CNC patients. The overall penetrance of CNC among PRKAR1A mutation carriers is near 98%. Most PRKAR1A mutations result in premature stop codon generation and lead to nonsense-mediated mRNA decay. CNC is genetically and clinically heterogeneous, with specific mutations providing some genotype-phenotype correlation. Phosphodiesterase-11A (the PDE11A gene) and -8B (the PDE8B gene) mutations were found in patients with isolated adrenal hyperplasia and Cushing syndrome, as well in patients with PPNAD. Recent evidences demonstrated that dysregulation of cAMP/PKA pathway can modulate other signaling pathways and contributes to adrenocortical tumorigenesis. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115159      PMCID: PMC3000540          DOI: 10.1016/j.beem.2010.10.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  51 in total

1.  Heterogeneity of skin manifestations in patients with Carney complex.

Authors:  Christine Mateus; André Palangié; Nathalie Franck; Lionel Groussin; Xavier Bertagna; Marie-Françoise Avril; Jérôme Bertherat; Nicolas Dupin
Journal:  J Am Acad Dermatol       Date:  2008-09-19       Impact factor: 11.527

2.  Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).

Authors:  S B Raff; J A Carney; D Krugman; J L Doppman; C A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2000-04       Impact factor: 1.634

3.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

4.  Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

Authors:  Jérôme Bertherat; Anélia Horvath; Lionel Groussin; Sophie Grabar; Sosipatros Boikos; Laure Cazabat; Rosella Libe; Fernande René-Corail; Sotirios Stergiopoulos; Isabelle Bourdeau; Thalia Bei; Eric Clauser; Alain Calender; Lawrence S Kirschner; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

5.  Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling.

Authors:  Madson Q Almeida; Michael Muchow; Sosipatros Boikos; Andrew J Bauer; Kurt J Griffin; Kit Man Tsang; Chris Cheadle; Tonya Watkins; Feng Wen; Matthew F Starost; Ioannis Bossis; Maria Nesterova; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2010-01-15       Impact factor: 6.150

6.  The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.

Authors:  Estelle Louiset; Constantine A Stratakis; Véronique Perraudin; Kurt J Griffin; Rossella Libé; Sylvie Cabrol; Bruno Fève; Jacques Young; Lionel Groussin; Jérôme Bertherat; Hervé Lefebvre
Journal:  J Clin Endocrinol Metab       Date:  2009-04-21       Impact factor: 5.958

Review 7.  Carney complex and lentiginosis.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-24       Impact factor: 4.693

8.  Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.

Authors:  Bruno Ragazzon; Laure Cazabat; Marthe Rizk-Rabin; Guillaume Assie; Lionel Groussin; Hélène Fierrard; Karine Perlemoine; Antoine Martinez; Jérôme Bertherat
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

9.  Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.

Authors:  Alberto M Pereira; Frederik J Hes; Anelia Horvath; Sanne Woortman; Elizabeth Greene; Eirini Bimpaki; Anton Alatsatianos; Sosipatros Boikos; Johannes W Smit; Johannes A Romijn; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

Review 10.  New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2008-11-21       Impact factor: 4.102

View more
  23 in total

Review 1.  Large-cell calcifying Sertoli cell tumors of the testes in pediatrics.

Authors:  Evgenia Gourgari; Emmanouil Saloustros; Constantine A Stratakis
Journal:  Curr Opin Pediatr       Date:  2012-08       Impact factor: 2.856

Review 2.  Cushing's Syndrome in Pediatrics: An Update.

Authors:  Maya B Lodish; Margaret F Keil; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

3.  Anesthetic experiences of myxoma removal surgery in two patients with Carney complex -A report of two cases-.

Authors:  Young Mi Kang; Yoon Hee Kim
Journal:  Korean J Anesthesiol       Date:  2011-12-20

4.  Novel Mutation in PRKAR1A in Carney Complex.

Authors:  Ko Un Park; Hyun-Sook Kim; Seung Kwan Lee; Woon-Won Jung; Yong-Koo Park
Journal:  Korean J Pathol       Date:  2012-12-26

5.  Circadian Plasma Cortisol Measurements Reflect Severity of Hypercortisolemia in Children with Different Etiologies of Endogenous Cushing Syndrome.

Authors:  Amit Tirosh; Maya B Lodish; Charalampos Lyssikatos; Elena Belyavskaya; Georgios Z Papadakis; Constantine A Stratakis
Journal:  Horm Res Paediatr       Date:  2017-04-21       Impact factor: 2.852

Review 6.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

Review 7.  Cushing syndrome.

Authors:  Bibek Bista; Nancy Beck
Journal:  Indian J Pediatr       Date:  2013-09-24       Impact factor: 1.967

8.  Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.

Authors:  Edra London; Anya Rothenbuhler; Maya Lodish; Evgenia Gourgari; Meg Keil; Charalampos Lyssikatos; Maria de la Luz Sierra; Nicolas Patronas; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2013-11-18       Impact factor: 5.958

Review 9.  PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.

Authors:  Annabel S Berthon; Eva Szarek; Constantine A Stratakis
Journal:  Front Cell Dev Biol       Date:  2015-05-20

10.  Residual manifestations of hypercortisolemia following surgical treatment in a patient with Cushing syndrome.

Authors:  Sara K Bartz; Lefkothea P Karaviti; Mary L Brandt; Monica E Lopez; Prakash Masand; Sridevi Devaraj; John Hicks; Lauren Anderson; Maya Lodish; Meg Keil; Constantine A Stratakis
Journal:  Int J Pediatr Endocrinol       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.